Annual report
150A.TEDINET S100YFUO
Period2025-04-01 → 2026-03-31
Filed2026-06-22
StandardJapan GAAP
ConsolidatedYes
Data checks23 of 23 passed
Key figures · 118
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | −¥106m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥176m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | −¥108m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥185m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | −¥126m | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥180m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥121m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥144m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥146m | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥144m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.8bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total liabilities | ¥1.8bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥944m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-03-31v | Cons. | Net assets |
| Cash and deposits | ¥885m | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥811m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥885m | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥811m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥39m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥138m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥653m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥691m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥766m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥168m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-21.44 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.67 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.22 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥342.29 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥362.46 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 51.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -6.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 579 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 488 | at 2025-03-31 | Cons. | Number of employees |
| Revenue | ¥4.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥4.0bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥3.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥37m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥186m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥41m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥194m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥195m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥161m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥83m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥58m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥189m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥78m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥153m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥145m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥188m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥61m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.8bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥889m | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.0bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥663m | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥836m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥774m | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2024-03-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥803m | at 2023-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥680m | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥300m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥225m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥145m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥117m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥195m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥211m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥94m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥486m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-13.79 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.33 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.29 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.25 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.33 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥26.85 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥31.27 | 2023-04-01 → 2024-03-31v | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥350.74 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥364.07 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥334.63 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥-258.78 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥-352.71 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.4% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.9% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -3.9% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.2% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.8% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 5,666,100 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,624,100 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,482,600 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 572 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 484 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 427 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 383 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 301 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 83
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2025-04-01 → 2026-03-31 | ¥6m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2026-03-31 | 7 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2026-03-31 | ¥113m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥94m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2026-03-31 | ¥112m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | −¥63m |
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥14m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥7m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥996m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥623m |
| Home Care Medicine Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥22m |
| Home Care Medicine Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥5m |
| Home Care Medicine Businessreportable segment | employees | at 2026-03-31 | 237 pure |
| Home Care Medicine Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Home Care Medicine Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Home Care Medicine Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥5m |
| Home Care Medicine Businessreportable segment | segment assets | at 2026-03-31 | ¥343m |
| Home Care Medicine Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥196m |
| Regional Revitalization Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥720m |
| Regional Revitalization Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥223m |
| Regional Revitalization Businessreportable segment | employees | at 2026-03-31 | 312 pure |
| Regional Revitalization Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥3.2bn |
| Regional Revitalization Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥3.2bn |
| Regional Revitalization Businessreportable segment | segment assets | at 2026-03-31 | ¥2.3bn |
| Regional Revitalization Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥776m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥742m |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥228m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥4.7bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥4.6bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥5m |
| —segment total | segment assets | at 2026-03-31 | ¥2.7bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥580m |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥748m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥229m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥517m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥2m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥1m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥957m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥545m |
| Home Care Medicine Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥822,000 |
| Home Care Medicine Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥4m |
| Home Care Medicine Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Home Care Medicine Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Home Care Medicine Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥390,000 |
| Home Care Medicine Businessreportable segment | segment assets | at 2025-03-31 | ¥295m |
| Home Care Medicine Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥165m |
| Regional Revitalization Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥803m |
| Regional Revitalization Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥139m |
| Regional Revitalization Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Regional Revitalization Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.5bn |
| Regional Revitalization Businessreportable segment | segment assets | at 2025-03-31 | ¥1.7bn |
| Regional Revitalization Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥555m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥804m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥143m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥390,000 |
| —segment total | segment assets | at 2025-03-31 | ¥2.0bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥720m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥804m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥721m |
| Home Care Medicine Businessreportable segment | employees | at 2026-03-31 | 237 pure |
| Regional Revitalization Businessreportable segment | employees | at 2026-03-31 | 312 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,511
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember | 1987351000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 1987351000 | JPY |
| Accumulated depreciation ppe by group | Prior1YearInstant_NonConsolidatedMember | -404820000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant_NonConsolidatedMember | -630013000 | JPY |
| Directors compensations sga | Prior1YearDuration_NonConsolidatedMember | 202279000 | JPY |
| Directors compensations sga | CurrentYearDuration_NonConsolidatedMember | 217473000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 374911000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 432890000 | JPY |
| Provision for bonuses sga | Prior1YearDuration_NonConsolidatedMember | 9280000 | JPY |
| Provision for bonuses sga | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 2078000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 2274000 | JPY |
| Legal welfare expenses sga | Prior1YearDuration_NonConsolidatedMember | 76459000 | JPY |
| Legal welfare expenses sga | CurrentYearDuration_NonConsolidatedMember | 85844000 | JPY |
| Advertising expenses sga | Prior1YearDuration_NonConsolidatedMember | 172530000 | JPY |
| Advertising expenses sga | CurrentYearDuration_NonConsolidatedMember | 130915000 | JPY |
| Commission fee sga | Prior1YearDuration_NonConsolidatedMember | 121085000 | JPY |
| Commission fee sga | CurrentYearDuration_NonConsolidatedMember | 173481000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 9069000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 14148000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration_NonConsolidatedMember | 1192000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration_NonConsolidatedMember | 98000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-06-22 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第10期(自 2025年４月１日 至 2026年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ＪＳＨ | |
| Company name in english cover page | FilingDateInstant | ＪＳＨ Ｃｏ.,Ｌｔｄ． | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長兼社長 野口 和輝 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋一丁目１番５号 セントラルビル | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-3272-0606(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営管理本部長 市川 伸二 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋一丁目１番５号 セントラルビル | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-3272-0606(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営管理本部長 市川 伸二 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E39184 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 150A0 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社JSH | |
| Filer name in english | FilingDateInstant | JSH Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 23 of 23 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |